HNRNPA2B1 and hypoparathyroidism-retardation-dysmorphism syndrome: Moreover, epigenetically, HRD can alter the levels of m6A and m5C in pSD patients, potentially by alterations to the expression of HNRNPA2B1 as a key regulator.